← Back to Search

Vitamin Supplement

vitamin D supplement for Orthostatic Intolerance

N/A
Waitlist Available
Led By Hossam Shaltout, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Study Summary

This trial is testing whether increasing vitamin D levels will help children with chronic nausea who have underlying cardiovascular problems.

Eligible Conditions
  • Orthostatic Intolerance
  • Vitamin D Deficiency
  • Nausea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of orthostatic intolerance symptoms usint tilt table test
Secondary outcome measures
improvement of nausea symptoms

Trial Design

1Treatment groups
Experimental Treatment
Group I: vitamin D supplementExperimental Treatment1 Intervention
patient's will be given a vitamin D
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
vitamin D supplement
2016
N/A
~110

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,241 Previous Clinical Trials
1,004,206 Total Patients Enrolled
Hossam Shaltout, PhDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
165 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025